Pyriform sinus cancer remains one of the most lethal of human diseases
. Regardless of approach attempted significant enhancement of survival
has not been realized, In this study a retrospective single instituti
onal review of all patients diagnosed with pyriform sinus cancer durin
g the 1980s was conducted, The results in 93 patients show an overall
determinant B-year survival of 14.3%, Of patients undergoing surgery,
median determinant survival was 37 months and B-year survival was 34.6
%. In resectable patients treated with radiation with or without chemo
therapy, median determinant survival was 13 months with B-year surviva
l of 7.1% (P<.01). Surgical salvage was attempted in 8 patients withou
t success. In conclusion, due to the apparent survival advantage for s
urgical patients, the low rate of surgical salvage, and the relatively
low rate of organ preservation in prospective trials, pyriform sinus
cancer is a poor site for organ preservation. Surgery followed by radi
ation therapy should remain the standard of care for pyriform sinus ca
ncer.